{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:18:36Z","timestamp":1793035116043,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Diabetic retinopathy (DR) is a leading cause of blindness characterized by early neurovascular damage driven by hyperglycemia-induced mechanisms, including inflammation. The system composed of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) has previously emerged as a potential regulator of the pro-inflammatory events in DR, possibly through the interaction of uPAR with its lateral partners, such as formyl peptide receptors (FPRs). This study explored whether the inhibition of uPAR\/FPR1 crosstalk may reduce early neurovascular alterations in DR by targeting inflammation. To this aim, the new FPR1 antagonist N-19004 was tested in a rat model of streptozotocin-induced diabetes. N-19004 was administered subcutaneously for 7\u202fdays at 1\u202fmonth from diabetes onset. Immunofluorescence, RT-qPCR, Western blot and Evans blue perfusion were performed to evaluate the effects of N-19004 on inflammation, reactive gliosis, blood-retinal barrier (BRB) integrity and apoptosis. In addition, electroretinogram (ERG) was used to assess N-19004 efficacy on retinal function. N-19004 inhibited the activation of inflammation-related transcription factors, including nuclear factor kappa-light-chain-enhancer of activated B cells and signal transducer and activator of transcription 3, leading to reduced interleukin-1\u03b2 and tumor necrosis factor-\n                    <jats:italic>\u03b1<\/jats:italic>\n                    expression. The attenuation of inflammatory processes resulted in reduced glial activation, as indicated by lower glial fibrillary acidic protein expression and M\u00fcller cell gliosis. The anti-inflammatory activity of N-19004 was accompanied by decreased BRB breakdown, as demonstrated by N-19004-mediated reduction of vascular endothelial growth factor, increased levels of tight junction components and diminished vessel leakage. The amelioration of BRB integrity was associated with reduced activation of caspase 3 and partial preservation of scotopic ERG a- and b-wave amplitudes, thereby improving retinal viability and function in N-19004-treated STZ rats. These results support the possible involvement of uPAR\/FPR1 interactions in the regulation of DR-related inflammation and suggest a novel therapeutic target for the management of the early phases of disease.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2026.1872366","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:50:23Z","timestamp":1782910223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibiting the uPAR\/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes"],"prefix":"10.3389","volume":"20","author":[{"given":"Alessio","family":"Canovai","sequence":"first","affiliation":[{"name":"Department of Biology, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Amato","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Melecchi","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Fenza","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, University of Naples Federico II","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Pavone","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, University of Naples Federico II","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"D\u2019Alonzo","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, University of Naples Federico II","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cammalleri","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dal Monte","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa","place":["Pisa, Italy"]},{"name":"Interdepartmental Center Pisa Neuroscience \u201cPiNeuro\u201d, University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.sjopt.2018.05.002","article-title":"Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy","volume":"32","author":"Al-Kharashi","year":"2018","journal-title":"Saudi J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/iovs.66.11.29","article-title":"Inhibiting the uPA\/uPAR pathway affords photoreceptor resilience and preserves retinal function in a mouse model of retinitis pigmentosa","volume":"66","author":"Amato","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3390\/nu10121932","article-title":"Lisosan G protects the retina from neurovascular damage in experimental diabetic retinopathy","volume":"10","author":"Amato","year":"2018","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"23463","DOI":"10.1074\/jbc.274.33.23463","article-title":"Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors","volume":"274","author":"Antonetti","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1167\/iovs.15-18758","article-title":"The Urokinase receptor-derived peptide UPARANT mitigates angiogenesis in a mouse model of laser-induced choroidal neovascularization","volume":"57","author":"Cammalleri","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2904150","article-title":"Diabetic retinopathy in the spontaneously diabetic Torii rat: pathogenetic mechanisms and preventive efficacy of inhibiting the urokinase-type plasminogen activator receptor system","volume":"2017","author":"Cammalleri","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/cells8080925","article-title":"The uPAR system as a potential therapeutic target in the diseased eye","volume":"8","author":"Cammalleri","year":"2019","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1167\/iovs.17-21593","article-title":"The Urokinase receptor-derived peptide UPARANT recovers dysfunctional Electroretinogram and blood-retinal barrier leakage in a rat model of diabetes","volume":"58","author":"Cammalleri","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"811818","DOI":"10.3389\/fphar.2021.811818","article-title":"Preventive efficacy of an antioxidant compound on blood retinal barrier breakdown and visual dysfunction in Streptozotocin-induced diabetic rats","volume":"12","author":"Canovai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1167\/iovs.14-16323","article-title":"Antiangiogenic effectiveness of the Urokinase receptor-derived peptide UPARANT in a model of oxygen-induced retinopathy","volume":"56","author":"Dal Monte","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.drudis.2020.06.013","article-title":"COVID-19 and pneumonia: a role for the uPA\/uPAR system","volume":"25","author":"D'Alonzo","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"113674","DOI":"10.1016\/j.isci.2025.113674","article-title":"Dual-action thioarylamide-based small molecules to target drug-resistant bacteria and chronic inflammation","volume":"28","author":"De Fenza","year":"2025","journal-title":"iScience"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1021\/acsptsci.4c00366","article-title":"Turn-adopting peptidomimetic as a formyl peptide receptor-1 antagonist","volume":"7","author":"De Fenza","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/S0002-9440(10)64332-5","article-title":"Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor","volume":"162","author":"El-Remessy","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e71868","DOI":"10.1371\/journal.pone.0071868","article-title":"Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF\/uPAR pathway","volume":"8","author":"El-Remessy","year":"2013","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1167\/iovs.13-13562","article-title":"Pathologic alterations of the outer retina in streptozotocin-induced diabetes","volume":"55","author":"\u00c9nzs\u00f6ly","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4172\/2155-9570.1000298","article-title":"Modes of retinal cell death in diabetic retinopathy","volume":"4","author":"Feenstra","year":"2013","journal-title":"J Clin Exp Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/tvst.6.5.10","article-title":"Augmenting endogenous levels of retinal Annexin A1 suppresses uveitis in mice","volume":"6","author":"Gardner","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bcp.2017.06.130","article-title":"Sulodexide prevents activation of the PLA2\/COX-2\/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE\/RAGE","volume":"142","author":"Giurdanella","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.3390\/ijms24119352","article-title":"Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections","volume":"24","author":"Gonz\u00e1lez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jtcvs.2009.06.022","article-title":"Cerebral tumor necrosis factor alpha expression and long-term neurocognitive performance after cardiopulmonary bypass in rats","volume":"138","author":"Jungwirth","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"732015","DOI":"10.3389\/fcell.2021.732015","article-title":"Targeting the Urokinase-type plasminogen activator receptor (uPAR) in human diseases with a view to non-invasive imaging and therapeutic intervention","volume":"9","author":"Leth","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1097\/00029330-200812020-00018","article-title":"Caspase-dependent retinal ganglion cell apoptosis in the rat model of acute diabetes","volume":"121","author":"Li","year":"2008","journal-title":"Chin. Med. J."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1167\/iovs.16-19415","article-title":"Photoreceptor cells influence retinal vascular degeneration in mouse models of retinal degeneration and diabetes","volume":"57","author":"Liu","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00109-019-01794-w","article-title":"UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis","volume":"97","author":"Locri","year":"2019","journal-title":"J. Mol. Med. (Berl)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00109-020-01979-8","article-title":"Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy","volume":"98","author":"Locri","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"key":"ref27","first-page":"342","article-title":"Systematic method for determining an ideal housekeeping gene for real-time PCR analysis","volume":"19","author":"Mane","year":"2008","journal-title":"J. Biomol. Tech."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/cimb47010028","article-title":"Molecular findings before vision loss in the Streptozotocin-induced rat model of diabetic retinopathy","volume":"47","author":"Moldovan","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1167\/iovs.16-19909","article-title":"Molecular mechanisms mediating antiangiogenic action of the urokinase receptor-derived peptide UPARANT in human retinal endothelial cells","volume":"57","author":"Motta","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1096\/fj.08-110155","article-title":"A peptide inhibitor of the urokinase\/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes","volume":"22","author":"Navaratna","year":"2008","journal-title":"FASEB J."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/cells10010177","article-title":"Autophagy involvement in the postnatal development of the rat retina","volume":"10","author":"Pesce","year":"2021","journal-title":"Cells"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/cells9061452","article-title":"Oxidative stress induces a VEGF autocrine loop in the retina: relevance for diabetic retinopathy","volume":"9","author":"Rossino","year":"2020","journal-title":"Cells"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00125-009-1655-6","article-title":"Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes","volume":"53","author":"Sasaki","year":"2010","journal-title":"Diabetologia"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells14050376","article-title":"Diabetic retinopathy (DR): mechanisms, current therapies, and emerging strategies","volume":"14","author":"Seo","year":"2025","journal-title":"Cells"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3389\/fendo.2019.00843","article-title":"Diabetic retinopathy-an underdiagnosed and undertreated inflammatory, neuro-vascular complication of diabetes","volume":"10","author":"Sinclair","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1073\/pnas.1718592114","article-title":"Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy","volume":"114","author":"Thounaojam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia-neuron interactions in the mammalian retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.exer.2012.03.011","article-title":"Blockade of VEGF-induced GSK\/\u03b2-catenin signaling, uPAR expression and increased permeability by dominant negative p38\u03b1","volume":"100","author":"Yang","year":"2012","journal-title":"Exp. Eye Res."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1167\/iovs.08-2878","article-title":"Antipermeability function of PEDF involves blockade of the MAP kinase\/GSK\/beta-catenin signaling pathway and uPAR expression","volume":"51","author":"Yang","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e0299882","DOI":"10.1371\/journal.pone.0299882","article-title":"The effect of KUS121, a novel VCP modulator, against ischemic injury in random pattern flaps","volume":"19","author":"Yoshimoto","year":"2024","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/cells12091342","article-title":"Retinal cell damage in diabetic retinopathy","volume":"12","author":"Zhou","year":"2023","journal-title":"Cells"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1872366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:50:24Z","timestamp":1782910224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1872366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":43,"alternative-id":["10.3389\/fnins.2026.1872366"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1872366","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1872366"}}